Abstract: There is provided herein a compound of formula I, or pharmaceutically acceptable salt thereof, wherein R1 is as defined herein, for use in the prevention of thrombus formation and/or thrombus growth and/or in the prevention of haemorrhage. In particular, the compound is for use in the prevention of left ventricular thrombus formation and/or thrombus growth and/or intramyocardial haemorrhage in myocardial infarction patients and particularly in conjunction with standard antiplatelet and anticoagulant medications.

Abstract: There is provided herein a compound of formula I, or pharmaceutically acceptable salt thereof, wherein R1 is as defined herein, for use in the prevention of thrombus formation and/or thrombus growth and/or in the prevention of haemorrhage. In particular, the compound is for use in the prevention of left ventricular thrombus formation and/or thrombus growth and/or intramyocardial haemorrhage in myocardial infarction patients and particularly in conjunction with standard antiplatelet and anticoagulant medications.

Abstract: Disclosed is a process which achieves effective separation of components from red blood cells by aggregating cell membranes with an addition of a pH lowering agent, whereupon the solution is made subject to a separation step where a water soluble fraction is separated from cell membranes, and whereupon the cell membranes are extracted, and where lipids may be selectively separated and recovered by lowering the temperature of the extract.

Abstract: The present invention is related to an energy supply composition particularly suitable for use before, during and after physical exertion. The composition is a beverage, or a dry composition therefore, useful as an energy source in situations which demand a large and rapid energy supply to a healthy mammal including man. The beverage comprises an effective amount of alpha-ketoglutaric acid or a water-soluble innocuous salt thereof together with a nutritionally acceptable water-soluble carrier.

Abstract: The present invention relates to a process for reducing the excretion of nitrogen from humans and animals while maintaining formation of proteins, as well as a food and feedstuff for humans and animals comprising keto acids, whereby ingoing protein is replaced by alpha ketoglutaric acid; a combination of alpha keto glutaric acid and pyruvic acid; oxaloacetate or oxaloacetate in combination with alpha keto glutaric acid or pyruvate or another keto acid according to the formula R-CO-COOX, wherein R denotes a part of a non-essential amino acid and X denotes hydrogen, alkali metal, alkaline earth metal or organic base or non-toxic precursors or intermediates of these, whereby the keto acid (-s) is (are) present in an amount of 1 to 20% by weight, preferably 1-10% by weight of the protein dry matter present.

Abstract: The present invention relates to a process for reducing the excretion of nitrogen from humans and animals while maintaining formation of proteins, as well as a food and feedstuff for humans and animals comprising keto acids, whereby ingoing protein is replaced by alpha ketoglutaric acid; a combination of alpha keto glutaric acid and pyruvic acid; oxaloacetate or oxaloacetate in combination with alpha keto glutaric acid or pyruvate or another keto acid according to the formula R--CO--COOX, wherein R denotes a part of a non-essential amino acid and X denotes hydrogen, alkali metal, alkaline earth metal or organic base or non-toxic precursors or intermediates of these, whereby the keto acid (-s) is (are) present in an amount of 1 to 20% by weight, preferably 1-10% by weight of the protein dry matter present.